Sulaberidze G, Okujava M, Liluashvili K, Tughushi M, Bezarashvili S
The reduction in hepatic fat in HIV-associated fatty liver disease, alongside the primary visceral-fat effect, has been characterized in randomized trials, and the mechanistic follow-up identified reductions in fibro-inflammatory mediators (VEGFA, TGF-1, CSF1) that track with improvements in liver-injury scores
doi: 10.1016/j.ceca.2017.05.003 67 AnYWangXGuanXYuanPLiuYWeiLet al
The study planned to include 200 patients with type 2 diabetes who were not on any antidiabetic drugs in the 90 days prior to Visit 1 (except in certain clinical situations, such as acute illness, hospitalization, or elective surgery, short-term (14 days) use of insulin)
It works by reducing the appearance of dark spots, blemishes, and uneven skin tone
Allow 30-60 seconds between sprays to avoid mucosal oversaturation